Athira Pharma Presents Data from ACT-AD Phase 2
Additional data showed numerical improvement in activities of daily living (ADCS-ADL23), a protocoled secondary endpoint and a functional measure of...
United States Mark Litton Athira Pharma Julie Rathbun Hans Moebius Alzheimer Association International Conference
Source: globenewswire.com